WCBA
NUS icon

Weaver C. Barksdale & Associates’s Nu Skin NUS Stock Holding History

Weaver C. Barksdale & Associates’s Portfolio NUS Stock Details NUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$12K Sell
178
-5
-3% -$323 0.01% 246
2017
Q3 		$11K Sell
183
-17
-9% -$1.04K 0.01% 257
2017
Q2 		$13K Sell
200
-20
-9% -$1.14K 0.02% 216
2017
Q1 		$12K Buy
+220
New +$11.3K 0.01% 248

Other funds holding NUS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PGP
Prescott General Partners Boca Raton, Florida $1.37B AUM 23.81% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Weaver C. Barksdale & Associates's NUS Position: Q4 2017 in Review

Weaver C. Barksdale & Associates reduced its Nu Skin (NUS) stake by 2.7% in Q4 2017, selling an estimated $323 and leaving 178 shares worth $12K. The position accounts for 0.01% of the portfolio, ranked #246.

Weaver C. Barksdale & Associates first reported a position in NUS in Q1 2017 and has held it in 4 quarters since. The position peaked at $13K in Q2 2017. 273 funds tracked by Wall St. Rank hold NUS as of Q4 2017.

  • Weaver C. Barksdale & Associates held 178 shares of Nu Skin worth $12K as of Q4 2017.
  • Weaver C. Barksdale & Associates sold 5 Nu Skin shares in Q4 2017, an estimated $323.
  • Nu Skin made up 0.01% of Weaver C. Barksdale & Associates's portfolio in Q4 2017, its #246 holding.
  • Weaver C. Barksdale & Associates first reported a position in Nu Skin in Q1 2017 and has held it in 4 quarters since.
  • Weaver C. Barksdale & Associates's Nu Skin position peaked at $13K in Q2 2017.
  • 273 funds tracked by Wall St. Rank held Nu Skin as of Q4 2017.

Based on Weaver C. Barksdale & Associates's 13F filing for Q4 2017, filed 10 Jan 2018.